REC Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Recordati Industria Chimica e Farmaceutica SpA

Watchlist Manager

Watchlist

Price: 51.35 EUR 0.1% Market Closed

Market Cap: €10.7B

	Recordati Industria Chimica e Farmaceutica SpA MIL:REC	IT
T	TRYP Therapeutics Inc CNSX:TRYP	CA
	E-L Financial Corp Ltd TSX:ELF	CA
	Alfa Laval AB OTC:ALFVF	SE
	Xeris Biopharma Holdings Inc F:2B30	US

Profitability Summary

Recordati Industria Chimica e Farmaceutica SpA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

68%

Declining Gross Margin

70% > 68%

Healthy Operating Margin

27%

Sustainable 3Y Average Operating Margin

27%

Declining Operating Margin

27% > 27%

Healthy Net Margin

17%

Sustainable 3Y Average Net Margin

18%

Declining Net Margin

19% > 17%

Exceptional Free Cash Flow Margin

20%

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

22% > 20%

Positive ROE

23%

Positive 3Y Average ROE

Positive 3Y Average ROIC

13%

Declining ROIC

13% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.